back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-03-15 19:33 Tx date 2020-03-13 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$171,000
+900,000 vol $0.19 each |
1,850,000 | |
| Filed 2019-12-30 18:57 Tx date 2019-08-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-412,500
-150,000 vol $2.75 each |
950,000 | |
| Filed 2019-01-14 Tx date 2018-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-900,000
-600,000 vol $1.50 each |
150,000 | |
| Filed 2019-01-14 Tx date 2019-01-10 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,444,000
+950,000 vol $1.52 each |
1,100,000 | |
| Filed 2018-03-16 Tx date 2018-03-13 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-44,000
-176,000 vol $0.25 each |
750,000 | |
| Filed 2018-03-16 Tx date 2018-03-13 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$44,000
+176,000 vol $0.25 each |
340,000 | |
| Filed 2018-01-09 Tx date 2018-01-08 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-31,000
-124,000 vol $0.25 each |
926,000 | |
| Filed 2018-01-09 Tx date 2018-01-08 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$31,000
+124,000 vol $0.25 each |
164,000 | |
| Filed 2017-08-17 Tx date 2017-08-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$412,500
+150,000 vol $2.75 each |
1,050,000 | |
| Filed 2017-08-03 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Nicholas Rampertab (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-03 Tx date 2017-08-03 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Nicholas Rampertab (Control or Direction)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
1,000 | |
| Filed 2017-08-03 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Amanda Rampertab (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-03 Tx date 2017-08-03 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Amanda Rampertab (Control or Direction)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
1,000 | |
| Filed 2017-08-03 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Jacob Rampertab (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-03 Tx date 2017-08-03 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Jacob Rampertab (Control or Direction)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
1,000 | |
| Filed 2016-12-22 Tx date 2016-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$900,000
+600,000 vol $1.50 each |
900,000 | |
| Filed 2016-05-04 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2016-05-04 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
40,000 | ||
| Filed 2015-09-16 Tx date 2015-09-16 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rampertab, Shameze
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,700
+3,000 vol $0.90 each |
10,000 | |
| Filed 2015-09-13 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rampertab, Shameze
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-13 Tx date 2015-09-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rampertab, Shameze
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,440
+7,000 vol $0.92 each |
7,000 | |
| Filed 2015-06-12 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rampertab, Shameze
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
403,283 |